Dosing, Amgen
Showing 1 - 25 of 5,471
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Sumida City (CCX168, Placebo)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- Placebo
-
Sumida City, Tokyo, JapanSumida Hospital, SOUSEIKAI Global Clinical Research Center
Aug 4, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- +4 more
-
Tempe, ArizonaCelerion
Aug 15, 2023
Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)
Completed
- Multiple Myeloma
-
Scottsdale, Arizona
- +139 more
Sep 9, 2022
Vasculitis, Systemic Lupus Erythematosus (SLE) Trial in Allschwil (CCX168, Placebo)
Completed
- Vasculitis
- Systemic Lupus Erythematosus (SLE)
- CCX168
- Placebo
-
Allschwil, SwitzerlandCovance Clinical Research Unit (CRU) AG
Aug 2, 2023
Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)
Not yet recruiting
- Melanoma
- ABP 206
- +2 more
- (no location specified)
Jun 8, 2023
Small Cell Lung Carcinoma Trial in Worldwide (AMG 757, Pembrolizumab, CRS Mitigation Strategies)
Recruiting
- Small Cell Lung Carcinoma
- AMG 757
- +2 more
-
Duarte, California
- +34 more
Dec 6, 2022
Non-squamous NSCLC, Epithelial Ovarian Cancer Trial (AMG 794)
Not yet recruiting
- Non-squamous Non-small Cell Lung Cancer
- Epithelial Ovarian Cancer
- AMG 794
-
Orange, CaliforniaUniversity of California at Irvine
Jan 25, 2023
Advanced Solid Tumors Trial in Worldwide (AMG 650)
Active, not recruiting
- Advanced Solid Tumors
- AMG 650
-
Los Angeles, California
- +21 more
Jan 26, 2023
Chemo-induced Thrombocytopenia Trial in Worldwide (Romiplostim, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Romiplostim
- Placebo
-
Jonesboro, Arkansas
- +107 more
Feb 1, 2023
Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))
Recruiting
- Hyperlipidemias
- Evolocumab
- Statins (Cardiovascular Agents)
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 18, 2022
Metastatic Castration-resistant Prostate Cancer Trial in United States (AMG 340)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- AMG 340
-
San Francisco, California
- +6 more
Jul 14, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in Worldwide (acapatamab, Pembrolizumab, Etanercept)
Active, not recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- acapatamab
- +3 more
-
Campbell, California
- +29 more
Dec 6, 2022
DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)
Active, not recruiting
- Diffuse Large B-Cell Lymphoma (DLBCL)
- +4 more
- EPOCH
- Rituximab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Relapsed/Refractory Multiple Myeloma Trial (AMG 701)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- AMG 701
- (no location specified)
Jun 6, 2022
Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)
Not yet recruiting
- Lymphoblastic Leukemia
- Dexamethasone
- +8 more
-
Palo Alto, CaliforniaStanford University
Apr 27, 2023
Carfilzomib Among Multiple Myeloma Patients in Europe
Completed
- Multiple Myeloma
-
Braunau, Austria
- +114 more
Dec 8, 2022
Prostate Cancer Trial in Worldwide (AMG 509, Abiraterone, Enzalutamide)
Recruiting
- Prostate Cancer
- AMG 509
- +2 more
-
Duarte, California
- +18 more
Mar 17, 2022